Earnings4521KAKEN PHARMACEUTICAL CO.,LTD.
Kaken Pharmaceutical Q1 FY2027 Earnings Presentation: Revenue of 30.2 billion, +59.8% YoY
TOKYO, Aug 07 (Pulse News Wire) – KAKEN PHARMACEUTICAL CO.,LTD. (4521.T) released its earnings presentation for Q1 FY2027.
Revenue was ¥30.2 billion (+59.8% YoY). Operating profit was -¥900 million. Ordinary profit was ¥11.3 billion.
Total assets stood at ¥190 billion.
Financial results — FY2027/3 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥30,154M | +59.8% |
| Operating profit | ¥10,902M | +11258.0% |
| Net profit | n/a | n/a |
Next period forecast
Revenue
¥89,900M
+17.0%Op. profit
¥7,900M
+8600.0%Net profit
¥171M
n/aFigures in millions of yen
End of article